findmyKOL
Clinical trialNCT00664105TerminatedPhase 2Interventional

Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)

SponsorVanderbilt-Ingram Cancer CenterEnrollment63Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • M.D. Anderson Cancer Center, Orlando

    Orlando, Florida, United States

  • Chesapeake Oncology Hematology Associates

    Baltimore, Maryland, United States

  • University Hospital of Cleveland

    Cleveland, Ohio, United States

  • Lehigh Valley Hospital - John & Dorothy Morgan Cancer Center

    Allentown, Pennsylvania, United States

  • Erlanger Health System

    Chattanooga, Tennessee, United States

  • Clarksville Regional Hematology Oncology Group

    Clarksville, Tennessee, United States

  • Jackson Madison County Hospital

    Jackson, Tennessee, United States

  • Tennessee Cancer Specialists

    Knoxville, Tennessee, United States

  • University of Tennessee Medical Center

    Knoxville, Tennessee, United States

  • the West Clinic, Pc

    Memphis, Tennessee, United States

  • Meharry Medical College

    Nashville, Tennessee, United States

  • St. Thomas Health Services

    Nashville, Tennessee, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

  • Swedish Cancer Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2004
Primary completion
30 Jun 2008
Completion
30 Jun 2008
Last update posted
7 Sept 2012
Registered enrollment
63
Registry id
NCT00664105

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.